The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2003-10-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1365-2125.1997.00653.XPMID 9278198PMCID PMC2042830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Pharmacokinetics and Neuromuscular Effects of Rocuronium Bromide in Patients with Liver Disease

  1995cited by this paper
• Pharmacokinetics and Pharmacodynamics of Rocuronium in Patients with Cirrhosis

  1994cited by this paper
• Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure.

  1993cited by this paper
• Pharmacokinetics and Pharmacodynamics of Rocuronium (Org 9426) in Elderly Surgical Patients

  1993cited by this paper
• Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation.

  1992cited by this paper
• The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia.

  1991cited by this paper
• The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl

  1991cited by this paper
• The pharmacodynamics of alcuronium in the elderly

  1991cited by this paper
• The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat.

  1990cited by this paper
• Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.

  1989cited by this paper
• Vecuronium in Alcoholic Liver Disease: A Pharmacokinetic and Pharmacodynamic Analysis

  1988cited by this paper
• Pharmacokinetics and Pharmacodynamics of Vecuronium (ORG NC 45) in Patients with Cirrhosis

  1985cited by this paper
• Renal and Biliary Elimination of Vecuronium (ORG NC 45) and Pancuronium in Rats

  1982cited by this paper
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

  1980cited by this paper
• Fazadinium pharmacokinetics in patients with liver disease.

  1980cited by this paper
• Pancuronium pharmacokinetics in patients with liver cirrhosis.

  1979cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• Resistance to d-tubocurarine chloride in the presence of liver damage.

  1953cited by this paper

• General Anesthesia for a Child With a Living Donor Liver Transplant After Hepatoblastoma and Metastatic Lung Tumor Resection.

  2025cites this paper
• Rapid quantification and PK-PD modeling of rocuronium bromide in beagles using portable mass spectrometer

  2025cites this paper
• Residual Neuromuscular Block Remains a Safety Concern for Perioperative Healthcare Professionals: A Comprehensive Review

  2024cites this paper
• Pharmacodynamics and pharmacokinetics of rocuronium in sevoflurane-anesthetized Thoroughbred horses.

  2024cites this paper
• A Mini-review on the Necessity of Expanding Personalized Medicine for the Future of Various Aspects of Pain Management

  2024cites this paper
• Propriétés allergiques et activatrices de MRGPRX2 des médicaments : vers un algorithme mécanistique résolutif

  2024cites this paper
• Impact of Liver Disease on Use of Muscle Relaxants in Anesthesia: A Comprehensive Review

  2024cites this paper
• Diaphragm ultrasonography as a monitor in assessing antagonistic effect of sugammadex on rocuronium in patients with Child-Pugh grades A and B.

  2024cites this paper
• Neuromuscular end-point predictive capability of published rocuronium pharmacokinetic/pharmacodynamic models: An observational trial.

  2023cites this paper
• Clinical Guideline on Perioperative Management of Patients with Advanced Chronic Liver Disease

  2023cites this paper
• Influence of the Pringle maneuver during partial hepatectomy on the neuromuscular block induced by intermittent and continuous dosing of rocuronium

  2023cites this paper
• Allergenic and MRGPRX2-activating properties of drugs: resolving the two.

  2022cites this paper
• Mechanisms and implications in gene polymorphism mediated diverse reponses to sedatives, analgesics and muscle relaxants

  2022cites this paper
• Residual neuromuscular blockade in the ICU: a prospective observational study and national survey

  2022cites this paper
• MRGPRX2 and Adverse Drug Reactions

  2021cites this paper
• First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2

  2021cites this paper
• Personalized Medicine in Anesthesia, Pain and Perioperative Medicine

  2021cites this paper
• Prolonged onset and duration of action of rocuronium after accidental subcutaneous injection in a patient with chronic renal failure—a case report

  2021cites this paper
• Diaphragm ultrasound to evaluate the antagonistic effect of sugammadex on rocuronium after liver surgery in patients with different liver Child-Pugh grades: study protocol for a prospective, double-blind, non-randomised controlled trial

  2021cites this paper
• Polymorphisms contribute to differences in the effect of rocuronium in Chinese patients

  2021cites this paper
• Liver and Biliary Disease of Pregnancy and Anesthetic Implications: A Review.

  2021cites this paper
• Considerations in Neuromuscular Blockade in the ICU: A Case Report and Review of the Literature

  2020cites this paper
• Neuromuscular Blockade Correlates with Hormones and Body Composition in Acromegaly

  2020cites this paper
• Personalized Anesthetic Pharmacology

  2020cites this paper
• SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation

  2020cites this paper
• Challenges in anesthesia personalization: resolving the pharmacogenomic puzzle.

  2019cites this paper
• SUGAMMADEX ALWAYS FAST? PROBABLY YES, BUT IN LIVER TRANSPLANTATION

  2019cites this paper
• Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations

  2019cites this paper
• Grip strength can be used to evaluate postoperative residual neuromuscular block recovery in patients undergoing general anesthesia

  2019cites this paper
• Resistance towards nondepolarising muscle relaxants: prolonged onset time: A systematic review.

  2019cites this paper
• Essentials of Hepatology

  2019cites this paper
• Neuromuscular Blockers and Reversal Drugs

  2019cites this paper
• Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study.

  2018cites this paper
• Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant

  2018cites this paper
• Lethal injection with the muscle relaxant rocuronium

  2018cites this paper
• A systems-based approach to patient care after liver transplantation

  2018cites this paper
• The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries

  2017cites this paper
• Farmacología de los curares

  2017cites this paper
• Failed Vocalis Muscle Monitoring During Thyroid Surgery Resulting From Residual Muscle Relaxation.

  2017cites this paper
• Increased Renal Clearance of Rocuronium Compensates for Chronic Loss of Bile Excretion, via upregulation of Oatp2

  2017cites this paper
• Comparing early liver graft function from heart beating and living‐donors: A pilot study aiming to identify new biomarkers of liver injury

  2017cites this paper
• Rocuronium is more hepatotoxic than succinylcholine in vitro

  2017cites this paper
• Pharmacologie des curares

  2017cites this paper
• Farmacocinética y farmacodinamia

  2017cites this paper
• Physiology, Pathophysiology, and Anesthetic Management of Patients with Hepatic Disease

  2017cites this paper
• Dexamethasone Does Not Inhibit Sugammadex Reversal After Rocuronium-Induced Neuromuscular Block

  2016cites this paper
• Anesthetic Drugs Pharmacokinetics and Pharmacodynamics

  2016cites this paper
• Effect of ABCB1 rs12720464 and rs1055302 polymorphisms in Chinese patients on the time course of action of rocuronium administered as a single dose.

  2016cites this paper
• Is deep neuromuscular blockade beneficial in laparoscopic surgery? Yes, probably

  2016cites this paper
• Liver Disease and Liver Transplantation

  2015cites this paper
• Development of SPME method for concomitant sample preparation of rocuronium bromide and tranexamic acid in plasma.

  2014cites this paper
• Obstructive jaundice and perioperative management.

  2014cites this paper
• Analysis of rocuronium in human plasma by liquid chromatography-tandem mass spectrometry with application in clinical pharmacokinetics.

  2014cites this paper
• Prediction of human systemic, biologically relevant pharmacokinetic (PK) properties using quantitative structure pharmacokinetic relationships (QSPKR) and interspecies pharmacokinetic allometric scaling (PK-AS) approaches for four different pharmacological classes of compounds

  2014cites this paper
• Effect of pneumoperitoneum on the recovery from intense neuromuscular blockade by rocuronium in healthy patients undergoing laparoscopic surgery

  2014cites this paper
• Cisatracurium dose–response relationship in patients with chronic liver disease

  2014cites this paper
• Competitive Inhibition of the Nondepolarizing Muscle Relaxant Rocuronium on Nicotinic Acetylcholine Receptor Channels in the Rat Superior Cervical Ganglia

  2014cites this paper
• Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery.

  2014cites this paper
• Dexamethasone Produces Dose-Dependent Inhibition of Sugammadex Reversal in In Vitro Innervated Primary Human Muscle Cells

  2014cites this paper
• Drug absorption, distribution, metabolism and excretion considerations in critically ill adults

  2013cites this paper
• A disease-drug-phenotype matrix inferred by walking on a functional domain network.

  2013cites this paper
• SUGAMMADEX VERSUS NEOSTIGMINA EN LA REVERSION DE LA RELAJACION NEUROMUSCULAR EN NEUROCIRUGÍA. EXPERIMENTO CLINICO REPORTE PRELIMINAR

  2013cites this paper
• Anesthesiologist's satisfaction using between cisatracurium and rocuronium for the intubation in the anesthesia induced by remifentanil and propofol

  2013cites this paper
• Chapter 19 – Neuromuscular Blockers and Reversal Drugs

  2013cites this paper
• Influence of Obstructive Jaundice on Pharmacodynamics of Rocuronium

  2013cites this paper
• Monitoring and managing hepatic disease in anaesthesia.

  2013cites this paper
• Newer Neuromuscular Blocking Agents

  2012cites this paper
• The place of sugammadex in anaesthesia practice

  2012cites this paper
• Effects on Intubating Conditions of Pretreatment with Remifentanil before Administration of Cisatracurium

  2012cites this paper
• Rocuronium and sugammadex administration in patients undergoing orthotopic liver transplantation: 9AP4-8

  2012cites this paper
• Sugammadex does not influence thyroid hormones in the patients undergoing thyroidectomy in propofol anesthesia: 9AP4-4

  2012cites this paper
• Perioperatives anästhesiologisches Management bei ausgedehnten Leberteilresektionen

  2011cites this paper
• Is neuromuscular relaxation of rocuronium prolonged in patients with obstructive jaundice?

  2011cites this paper
• Analgesics and Neuromuscular Blocking Agents

  2011cites this paper
• Extremely prolonged neuromuscular block after cardiopulmonary resuscitation

  2011cites this paper
• Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.

  2010cites this paper
• Pharmacology of Muscle Relaxants and Their Antagonists

  2010cites this paper
• Farmacocinética y farmacodinamia del bromuro de rocuronio: Influencia de la terapia crónica con fenitoína.

  2010cites this paper
• Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.

  2009cites this paper
• Neuromuscular blocking drugs and their antagonists in patients with organ disease

  2009cites this paper
• Uncontrolled neuromuscular blockade increases morbidity in critically ill patients

  2009cites this paper
• How Should We Keep the Concentration of Rocuronium at an Adequate Level during Intraoperative Management

  2008cites this paper
• Utilización de bloqueantes neuromusculares en el paciente crítico

  2008cites this paper
• Pharmacokinetic–pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery

  2008influential citation
• Pharmacodynamics of rocuronium in cholestatic patients with or without hepatocellular injury: normal onset time of initial dose and prolonged duration time after repeated doses.

  2008cites this paper
• Improved Neuromuscular Blockade Using a Novel Neuromuscular Blockade Advisory System: A Randomized, Controlled, Clinical Trial

  2008cites this paper
• Development and pilot testing of the Neuromuscular Blockade Advisory System

  2008cites this paper
• 特殊な状態・病態におけるロクロニウムの使い方と留意点—肝臓・腎臓障害および移植術—

  2008cites this paper
• Prolonged residual paralysis after a single intubating dose of rocuronium.

  2007cites this paper
• Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium

  2007cites this paper
• Hepatobiliary Disease and Anaesthesia

  2006cites this paper
• The doughnut and the hole: a new pharmacological concept for anaesthetists.

  2006cites this paper
• BRITISH JOURNAL OF ANAESTHESIA

  2006cites this paper
• Neuromuscular Pharmacodynamics of Rocuronium in Patients with Major Burns

  2004cites this paper
• Rocuronium infusion requirements and plasma concentrations at constant levels of neuromuscular paralysis during three phases of liver transplantation.

  2003cites this paper
• Effect of Dexmedetomidine on Neuromuscular Blockade in Patients Undergoing Complex Major Abdmoinal or Pelvic Surgery

  2003cites this paper
• Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function.

  2002cites this paper
• The new neuromuscular blocking agents: do they offer any advantages?

  2001cites this paper
• Newer neuromuscular blocking agents: how do they compare with established agents?

  2001cites this paper
• Multicenter Trial of Prolonged Infusions of Rocuronium Bromide in Critically Ill Patients: Effects of Multiple Organ Failure

  2001cites this paper